ACORN FREELANCE

United States: Regenerative Medicine The U.S. Food and Drug Administration (FDA) is currently reviewing more than 800 investigational new...

I sighed inwardly as the Chief Medical Officer launched into another long story about the early days of the clinical research...

It seems many were flummoxed by the recent FDA approval of a label amendment for the established schizophrenia drug Invega Sustenna®. The...

"We need to fix this. But we do not need to undermine a working program that benefits patients by creating a deeply flawed alternative...